Trial Profile
Pharmacokinetics of WILATE and Haemate P in von Willebrand type 3 patients - a prospective, randomised, controlled, open-labelled, 2-arm cross-over study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Mar 2017
Price :
$35
*
At a glance
- Drugs Factor VIII/von Willebrand factor (Primary)
- Indications Von Willebrand disease
- Focus Pharmacokinetics
- Sponsors Octapharma
- 03 Mar 2017 New trial record